摘要
ACP Journal Club5 March 2024In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 yIlya Y. Shadrin, MD, PhD, L. Kristin Newby, MD, MHSIlya Y. Shadrin, MD, PhDDuke University School of Medicine, Durham, North Carolina, USA (I.Y.S., L.K.N.), L. Kristin Newby, MD, MHSDuke University School of Medicine, Durham, North Carolina, USA (I.Y.S., L.K.N.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/J24-0002 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationHealey JS, Lopes RD, Granger CB, et al; ARTESIA Investigators. Apixaban for stroke prevention in subclinical atrial fibrillation. N Engl J Med. 2024;390:107-117. https://pubmed.ncbi.nlm.nih.gov/37952132Clinical Impact RatingsGIM/FP/GP: Cardiology: References1. Kirchhof P, Toennis T, Goette A, et al; NOAH-AFNET 6 Investigators. Anticoagulation with edoxaban in patients with atrial high-rate episodes. N Engl J Med. 2023;389:1167-1179. [PMID: 37622677] Google Scholar2. Sabbag A, Berkovich A, Raanani E, et al. Subclinical postoperative atrial fibrillation: a randomized trial. Front Cardiovasc Med. 2023;10:1153275. [PMID: 37304958] Google Scholar3. Pepplinkhuizen S, Hoeksema WF, van der Stuijt W, et al. Accuracy and clinical relevance of the single-lead Apple Watch electrocardiogram to identify atrial fibrillation. Cardiovasc Digit Health J. 2022;3:S17-S22. [PMID: 36589758] Google Scholar4. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1-e156. [PMID: 38033089] Google Scholar Author, Article, and Disclosure InformationAuthors: Ilya Y. Shadrin, MD, PhD; L. Kristin Newby, MD, MHSAffiliations: Duke University School of Medicine, Durham, North Carolina, USA (I.Y.S., L.K.N.)Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=J24-0002.This article was published at Annals.org on 5 March 2024.ACP Journal Club is editorially independent from Annals of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics LatestKeywordsApixabanAspirinAtrial fibrillationClinical trialsEmbolismHemorrhageMedical risk factorsRandomized trialsStroke ePublished: 5 March 2024 Copyright & PermissionsCopyright © 2024 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...